Thyroid Medication Recalled Across the United States: Check If Your Treatment Is Affected
Posted on 08/04/26 at 14:04
- Thyroid medication recalled.
- Check the affected lot number.
- Consult your doctor.
Thousands of patients who use levothyroxine sodium to treat thyroid disorders could be affected by a nationwide Levothyroxine recall announced by manufacturer Major Rugby.
The company notified distributors and retailers of the recall through a letter sent earlier this month.
The recall involves several lots of tablets sold under the Major and Cardinal brands that were distributed across the United States.
Although the company said the health risk is low, it urged consumers to check their medications and return any affected products.
Levothyroxine Recall Affects Prescription Thyroid Medication

Thyroid medication recalled across the United States – Photo: Shutterstock
Major Rugby has recalled 12 different strengths and presentations of levothyroxine sodium tablets.
The affected products include bottles containing 100 tablets as well as unit-dose blister packs with 10 tablets.
YOU MAY ALSO BE INTERESTED IN: Publix Expands Frozen Fruit Recall Over Possible E. coli Contamination: Here’s What You Need to Check
According to the Mayo Clinic, levothyroxine is used to treat hypothyroidism, enlargement of the thyroid gland (goiter), and a type of thyroid cancer.
According to the manufacturer’s recall notice, the affected products have been distributed nationwide since January 2025.
Manufacturer Says the Health Risk Is Low
Major Rugby stated that taking the recalled medications “is not likely to cause adverse health effects.”
However, the company recommends returning the affected tablets to the place of purchase so the recall process can be completed.
The letter sent to retailers and a report from the U.S. Food and Drug Administration (FDA) indicate that the tablets are subpotent.
This means they contain less of the active ingredient than required to provide the intended therapeutic dose during treatment.
Patients Should Review Their Treatment and Consult Their Doctor
The manufacturer also advised anyone who identifies one of the recalled products to consult their healthcare provider.
The recommendation is intended to ensure that patients receive medical guidance before making any changes to their treatment.
The recalled tablets are limited to specific lots and product presentations marketed under the Major and Cardinal brands.
Health authorities continue to share information to help consumers identify the affected products included in the Levothyroxine recall.